Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.

MLA

Bastiaansen, Anna E. M., et al. “Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.” Neurology(R) Neuroimmunology & Neuroinflammation, vol. 9, no. 2, Dec. 2021. EBSCOhost, https://doi.org/10.1212/NXI.0000000000001127.

APA

Bastiaansen, A. E. M., de Bruijn, M. A. A. M., Schuller, S. L., Martinez-Hernandez, E., Brenner, J., Paunovic, M., Crijnen, Y. S., Mulder, M. J. H. L., Schreurs, M. W. J., de Graaff, E., Smitt, P. A. E., Neuteboom, R. F., de Vries, J. M., & Titulaer, M. J. (2021). Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy. Neurology(R) Neuroimmunology & Neuroinflammation, 9(2). https://doi.org/10.1212/NXI.0000000000001127

Chicago

Bastiaansen, Anna E M, Marienke A A M de Bruijn, Sabine L Schuller, Eugenia Martinez-Hernandez, Juliëtte Brenner, Manuela Paunovic, Yvette S Crijnen, et al. 2021. “Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.” Neurology(R) Neuroimmunology & Neuroinflammation 9 (2). doi:10.1212/NXI.0000000000001127.